NCT02130713View on ClinicalTrials.gov

Treatment of Chronic Bacterial Prostatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Chronic Bacterial Prostatitis
Interventions
DRUG

Third generation fluoroquinolone

Prulifloxacin 600 mg

DIETARY_SUPPLEMENT

Nutritional supplement + third generation fluoroquinolone

Serenoa repens 320 mg, Lactobacillus Sporogens 200 mg, Arbutin 100 mg and prulifloxacin 600 mg

Trial Locations (1)

00161

policlinico Umberto I - Department of Gynecological-Obstetrics Sciences and Urological Sciences, Roma

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02130713 - Treatment of Chronic Bacterial Prostatitis | Biotech Hunter | Biotech Hunter